CVS's most recent trend suggests a bullish bias. One trading opportunity on CVS is a Bull Put Spread using a strike $75.00 short put and a strike $70.00 long put offers a potential 6.38% return on risk over the next 3 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $75.00 by expiration. The full premium credit of $0.30 would be kept by the premium seller. The risk of $4.70 would be incurred if the stock dropped below the $70.00 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for CVS is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for CVS is bullish.
The RSI indicator is at 63.54 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for CVS
Top Stock Reports for JPMorgan, Mastercard & AbbVie
Fri, 14 Sep 2018 14:52:02 +0000
Top Stock Reports for JPMorgan, Mastercard & AbbVie
What employers needs to know about trends in health care and benefits
Fri, 14 Sep 2018 14:17:06 +0000
In a competitive market for skilled workers, it's vital for employers to offer good health benefits. We asked a panel of leaders in the local health care and benefits industries what you should know.
See what the IHS Markit Score report has to say about CVS Health Corp.
Thu, 13 Sep 2018 12:00:54 +0000
CVS Health Corp NYSE:CVS
CVS Health Applauds FDA's Steps to Address the Epidemic of Youth Use of Electronic Cigarettes and Vaping Devices
Wed, 12 Sep 2018 18:11:00 +0000
WOONSOCKET, R.I., Sept. 12, 2018 /PRNewswire/ — As the nation's first and only national pharmacy chain to have eliminated the sale of cigarettes and other harmful tobacco products from its retail stores – and having never sold e-cigarettes and vaping devices – CVS Health (CVS) today applauded the enforcement actions taken by the U.S. Food and Drug Administration (FDA) to curtail the sale and marketing of e-cigarettes to the nation's youth. “We applaud the historic enforcement actions announced today by FDA Commissioner Dr. Scott Gottlieb, and believe they represent the most important step the agency has taken to date to curtail youth use of e-cigarettes and flavored nicotine products,” said Troyen Brennan, M.D., M.P.H. and Chief Medical Officer for CVS Health.
Aetna Stock Should Have More Upside, But There’s One Key Risk
Tue, 11 Sep 2018 22:04:31 +0000
Aetna (NYSE:AET) stock has soared of late, for two key reasons. First, a takeout of Aetna stock by CVS (NYSE:CVS) appears increasingly likely to pass regulatory muster. Secondly, CVS stock, a component of the consideration paid for AET stock, has gained, increasing the value of the offer.
Related Posts
Also on Market Tamer…
Follow Us on Facebook